Sunshine Lake Pharma Co., Ltd.
6887.HK
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.86B
Close$
Share Statistics
| Market cap | $12.86 Billion |
|---|---|
| Enterprise Value | - |
| Dividend Yield | $- (NaN%) |
| Earnings per Share | $- |
| Beta | -0.1 |
| Outstanding Shares | - |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sunshine Lake Pharma Co., Ltd.
6,299 employees
CEO: Wen Jia Li Sunshine Lake Pharma Co., Ltd. operates as a pharmaceutical company. It engages in the research, development, production and commercialization of modified new drugs, generic drugs and biosimilars. The company was founded on December 29, 2003 and is headquartered in Dongguan, China.